SU2C and Farrah Fawcett Foundation Announce Formation of Research Team Dedicated to HPV-Related Cancers
April 8, 2014
This article was reported by News Medical.
News Medical reported that two distinguished cancer research foundations recently formed a collaborative research team dedicated to human papillomavirus (HPV)-related cancers. The Farrah Fawcett Foundation and Stand Up To Cancer (SU2C), along with the American Association for Cancer Research (AACR), SU2C's scientific partner, announced the partnership this week at AACR's annual meeting. The team will focus on HPV cancer patients who either relapse after initial therapy or have limited therapeutic options available to them.
The research project, called "Therapeutic CD8 Vaccines Against Conserved E7 HPV Epitopes Identified by MS," will be led by Ellis L. Reinherz, MD, chief of the Laboratory of Immunobiology and co-director of the Cancer Vaccine Center at Dana-Farber Cancer Institute, and Robert I. Haddad, MD, disease center leader for head and neck oncology at Dana-Farber. The two research foundations are backing the project with a $1.2 million three-year grant. Support for the translational research team is made possible with an additional gift from the HPV and Anal Cancer Foundation.View Full Article
Add Your Comment:
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)